Incorporating Considerations of Resources Use into Grading Recommendations_Chinese Journal of Evidence-Based Medicine

Authors：

Gordon H Guyatt , Andrew D Oxman , Regina Kunz , Roman Jaeschke , Mark Helfand , Alessandro Liberati , Gunn E Vist , Holger J Schnemann , for the GRADE group

Corresponding author：

Keywords：

DOI：

10.7507/1672-2531.20090109

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： Gordon H Guyatt,Andrew D Oxman,Regina Kunz,Roman Jaeschke,Mark Helfand,Alessandro Liberati,Gunn E Vist,Holger J Schnemann,for the GRADE group. Incorporating Considerations of Resources Use into Grading Recommendations. Chinese Journal of Evidence-Based Medicine, 2009, 09(6): 610-613. doi: 10.7507/1672-2531.20090109 Copy

1.	Guyatt G, Baumann M, Pauker S, et al. Addressing resource allocation issues in recommendations from clinical practice guideline panels: suggestions from an American College of Chest Physicians task force. Chest, 2006, 129(1): 182-187.
2.	Eddy DM. Comparing benefits and harms: the balance sheet. JAMA, 1990, 263(18): 2493, 2498, 2501.
3.	Magpie Trial Collaborative Group. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The magpie trial: a randomised placebo-controlled trial. Lancet, 2002, 359(9321): 1877-1890.
4.	Simon J, Gray A, Duley L. Cost-effectiveness of prophylactic magnesium sulphate for 9996 women with pre-eclampsia from 33 countries: economic evaluation of the magpie trial. Br J Obstet Gynaecol, 2006, 113(2): 144-151.
5.	Montori VM, Jaeschke R, Schünemann HJ, et al. Users’ guide to detecting misleading claims in clinical research reports. BMJ, 2004, 329(7474): 1093-1096.
6.	Luce B, Manning W, Siegel J. Estimating costs in cost-effectiveness analysis. In: Gold MR, Siegel JE, Russell LB, Weinstein MC, eds. Cost-effectiveness in health and medicine. Oxford: Oxford University Press, 1996: 176-213.
7.	Friedberg M, Saffran B, Stinson TJ, et al. Evaluation of conflict of interest in economic analyses of new drugs used in oncology. JAMA, 1999, 282(15): 1453-1457.
8.	Garber AM, Phelps CE. Economic foundations of cost-effectiveness analysis. J Health Econ, 1997, 16(1): 1-31.
9.	Owens DK. Interpretation of cost-effectiveness analyses. J Gen Intern Med, 1998, 13(10): 716-717.
10.	Gold M, Siegel JE, Russell LB, et al. Cost-effectiveness in health and medicine. Oxford: Oxford University Press, 1996.
11.	O’Brien B, Drummond M, Richardson WS, et al. Economic analysis. In: Guyatt G, Rennie D, eds. Users’ guides to the medical literature. Chicago: AMA Press, 2002, 621-644.

1. Guyatt G, Baumann M, Pauker S, et al. Addressing resource allocation issues in recommendations from clinical practice guideline panels: suggestions from an American College of Chest Physicians task force. Chest, 2006, 129(1): 182-187.
2. Eddy DM. Comparing benefits and harms: the balance sheet. JAMA, 1990, 263(18): 2493, 2498, 2501.
3. Magpie Trial Collaborative Group. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The magpie trial: a randomised placebo-controlled trial. Lancet, 2002, 359(9321): 1877-1890.
4. Simon J, Gray A, Duley L. Cost-effectiveness of prophylactic magnesium sulphate for 9996 women with pre-eclampsia from 33 countries: economic evaluation of the magpie trial. Br J Obstet Gynaecol, 2006, 113(2): 144-151.
5. Montori VM, Jaeschke R, Schünemann HJ, et al. Users’ guide to detecting misleading claims in clinical research reports. BMJ, 2004, 329(7474): 1093-1096.
6. Luce B, Manning W, Siegel J. Estimating costs in cost-effectiveness analysis. In: Gold MR, Siegel JE, Russell LB, Weinstein MC, eds. Cost-effectiveness in health and medicine. Oxford: Oxford University Press, 1996: 176-213.
7. Friedberg M, Saffran B, Stinson TJ, et al. Evaluation of conflict of interest in economic analyses of new drugs used in oncology. JAMA, 1999, 282(15): 1453-1457.
8. Garber AM, Phelps CE. Economic foundations of cost-effectiveness analysis. J Health Econ, 1997, 16(1): 1-31.
9. Owens DK. Interpretation of cost-effectiveness analyses. J Gen Intern Med, 1998, 13(10): 716-717.
10. Gold M, Siegel JE, Russell LB, et al. Cost-effectiveness in health and medicine. Oxford: Oxford University Press, 1996.
11. O’Brien B, Drummond M, Richardson WS, et al. Economic analysis. In: Guyatt G, Rennie D, eds. Users’ guides to the medical literature. Chicago: AMA Press, 2002, 621-644.

Chinese Journal of Evidence-Based Medicine

Incorporating Considerations of Resources Use into Grading Recommendations

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content